Today’s Decision In PLIVA Is A Sequel to Wyeth Two Years Later Except With a Happier Ending for Corporate America

Washington, DC – On news that the U.S. Supreme Court issued its opinion in PLIVA Inc. v. Mensing this morning, Constitutional Accountability Center, which filed an amicus curiae brief in support of respondents Gladys Mensing and Julie Demahy, released the following statement:

    “Today’s decision is wildly out of step not only with common sense, but also with Wyeth v. Levine – decided just two years ago,” stated CAC’s Chief Counsel Elizabeth Wydra. “Under the Court’s decision today, if a doctor prescribes a brand-name drug to a patient, but the pharmacist – in accordance with law – dispenses a lower-priced generic drug as an alternative, a claim by the patient against the generic drug manufacturer is pre-empted. Yet it wouldn’t have been if the brand-name drug had been used instead. This is an absurd result for America’s consumers that, as Justice Sotomayor put it, ‘makes little sense.’”

    “PLIVA had a duty under federal law to report problems with its drugs,” added CAC President Doug Kendall, “and failed to comply with that duty. To find impossibility preemption in this context is to twist the word ‘impossibility’ beyond recognition. The Court today gave generic drug manufacturers the benefit of a federal law without requiring them to fulfill their federal duty,” Kendall said.

    Wydra concluded, “This ruling simply cannot be squared with the Court’s decision in Wyeth, in which it ruled against preemption for brand-name drug manufacturers in virtually identical circumstances. Today’s decision is a sequel to Wyeth two years later, except with a happier ending for corporate America.”

#

Resources:

Constitutional Accountability Center’s case page for PLIVA, Inc. v. Mensing, including a link to our brief: http://theusconstitution.org/cases/pliva-inc-v-mensing

##

Constitutional Accountability Center (www.theusconstitution.org) is a think tank, public interest law firm, and action center dedicated to fulfilling the progressive promise of the Constitution’s text and history.

###

More from

Corporate Accountability
 

Intuit, Inc. v. Federal Trade Commission

In Intuit Inc v. Federal Trade Commission, the United States Court of Appeals for the Fifth Circuit is considering whether the FTC’s authority to issue cease-and-desist orders against false and misleading advertising is constitutional.
Rule of Law
June 20, 2024

Opinion | The tragedy of the Supreme Court’s bump stock ruling

Washington Post
Don’t let technicalities, or a refusal to use common sense, become the enemy of public...
By: Nina Henry
Access to Justice
June 20, 2024

RELEASE: Supreme Court rejects artificial limit on liability for speech-based retaliation by government officers

WASHINGTON, DC – Following today’s Supreme Court decision in Gonzalez v. Trevino, a case in...
By: Brian R. Frazelle
Civil and Human Rights
June 20, 2024

RELEASE: Supreme Court decision keeps the door open to accountability for police officers who make false charges

WASHINGTON, DC – Following this morning’s decision at the Supreme Court in Chiaverini v. City...
By: Brian R. Frazelle
Corporate Accountability
June 20, 2024

RELEASE: In narrow ruling, Supreme Court rejects baseless effort to shield corporate-derived income from taxation

WASHINGTON, DC – Following this morning’s decision at the Supreme Court in Moore v. United...
By: Brian R. Frazelle
Rule of Law
June 19, 2024

The Supreme Court’s approach on ‘history and tradition’ is irking Amy Coney Barrett

CNN
Washington (CNN) — On a Supreme Court where the conservative supermajority increasingly leans on history as a...
By: Elizabeth B. Wydra, Devan Cole, John Fritze